|
|
||||||||
Original Articles |
High retention of inhaled glucocorticoids in the airways means prolonged anti-inflammatory action and low delivery into the serum. The objective of this study was to investigate the retention in and distribution of inhaled fluticasone propionate (FP) between central and peripheral human lung tissue and serum in vivo. In 17 patients undergoing lung resection surgery, a single 1.0 mg dose of FP was inhaled at varying time-points (range 2.8-21.7 h) preoperatively. Peripheral and central lung tissue was obtained, and blood was drawn simultaneously. FP concentrations in central lung tissue were approximately three to four times higher than peripheral lung tissue concentrations, which in turn, exceeded those found in serum by 10 times. FP was detectable up to 21 and 16 h, respectively, after inhalation, with drug levels falling almost in parallel in peripheral lung tissue and in serum. The results of this study demonstrate that fluticasone propionate is retained in lung tissue for a long time. Serum concentrations after a single inhaled dose are low. Retention of high concentrations of fluticasone propionate in the airways may promote high topical anti-inflammatory activity.
This article has been cited by other articles:
![]() |
E. S. Mendes, G. Horvath, P. Rebolledo, M. E. Monzon, S. M. Casalino-Matsuda, and A. Wanner Effect of an inhaled glucocorticoid on endothelial function in healthy smokers J Appl Physiol, July 1, 2008; 105(1): 54 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Derendorf Pharmacokinetic and Pharmacodynamic Properties of Inhaled Ciclesonide J. Clin. Pharmacol., June 1, 2007; 47(6): 782 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Dorscheid, B. J. Patchell, O. Estrada, B. Marroquin, R. Tse, and S. R. White Effects of corticosteroid-induced apoptosis on airway epithelial wound closure in vitro Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L794 - L801. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fouty, T. Moss, V. Solodushko, and M. Kraft Dexamethasone can stimulate G1-S phase transition in human airway fibroblasts in asthma Eur. Respir. J., June 1, 2006; 27(6): 1160 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Edwards, M. W. Johnson, and S. L. Johnston Combination Therapy: Synergistic Suppression of Virus-Induced Chemokines in Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 616 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Dijkstra, J M Vonk, H Jongepier, G H Koppelman, J P Schouten, N H T ten Hacken, W Timens, and D S Postma Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex Thorax, February 1, 2006; 61(2): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Todorova, E. Gurcan, A. Miller-Larsson, and G. Westergren-Thorsson Lung Fibroblast Proteoglycan Production Induced by Serum Is Inhibited by Budesonide and Formoterol Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 92 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Biggadike, I. Uings, and S. N. Farrow Designing Corticosteroid Drugs for Pulmonary Selectivity Proceedings of the ATS, December 1, 2004; 1(4): 352 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Horvath, Z. Sutto, A. Torbati, G. E. Conner, M. Salathe, and A. Wanner Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L829 - L837. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Escotte, O. Tabary, D. Dusser, C. Majer-Teboul, E. Puchelle, and J. Jacquot Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-{beta} kinase pathway Eur. Respir. J., April 1, 2003; 21(4): 574 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Tulic and Q. Hamid Contribution of the Distal Lung to the Pathologic and Physiologic Changes in Asthma: Potential Therapeutic Target Roger S. Mitchell Lecture Chest, March 1, 2003; 123(2007): 348S - 355S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Carayol, I. Vachier, P. Chanez, A. M. Vignola, G. Chiappara, D. R. Dorscheid, and S. R. White Corticosteroid-induced epithelial shedding in asthma Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1290 - 1291. [Full Text] |
||||
![]() |
A. Miller-Larsson, A. R&D, O. Selroos, D. R. Dorscheid, and S. R. White No Evidence of Glucocorticosteroid-induced Apoptosis of Airway Epithelial Cells In Vivo Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1567 - 1568. [Full Text] |
||||
![]() |
D. R. DORSCHEID, K. R. WOJCIK, S. SUN, B. MARROQUIN, and S. R. WHITE Apoptosis of Airway Epithelial Cells Induced by Corticosteroids Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1939 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MILLER-LARSSON, P. JANSSON, A. RUNSTROM, and R. BRATTSAND Prolonged Airway Activity and Improved Selectivity of Budesonide Possibly Due to Esterification Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1455 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. ZuWallack, J. Adelglass, D. P. Clifford, S. P. Duke, P. D. Wire, M. Faris, and S. M. Harding Long-term Efficacy and Safety of Fluticasone Propionate Powder Administered Once or Twice Daily via Inhaler to Patients With Moderate Asthma Chest, August 1, 2000; 118(2): 303 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. JAFFUEL, P. DEMOLY, C. GOUGAT, P. BALAGUER, G. MAUTINO, P. GODARD, J. BOUSQUET, and M. MATHIEU Transcriptional Potencies of Inhaled Glucocorticoids Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 57 - 63. [Abstract] [Full Text] |
||||
![]() |
R J Meijer, H A M Kerstjens, L R Arends, H F Kauffman, G H Koëter, and D S Postma Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma Thorax, October 1, 1999; 54(10): 894 - 899. [Abstract] [Full Text] |
||||
![]() |
M. PALMQVIST, T. IBSEN, A. MELLÉN, and J. LÖTVALL Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 244 - 249. [Abstract] [Full Text] |
||||
![]() |
A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek, and R. Brattsand Reversible Fatty Acid Conjugation of Budesonide. Novel Mechanism for Prolonged Retention of Topically Applied Steroid in Airway Tissue Drug Metab. Dispos., July 1, 1998; 26(7): 623 - 630. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |